Pre-eclampsia: A maternal manifestation of a fetal adaptive response?

Ultrasound in Obstetrics and Gynecology

Volumn 38, Issue 4, 2011, Pages 367-370

  Espinoza, J ^a   Espinoza, A F ^b  

^a OAKLAND UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERYL TRINITRATE;

BLOOD FLOW VELOCITY; DRUG EFFECT; FEMALE; HUMAN; MIDDLE CEREBRAL ARTERY; NOTE; PLACENTA INSUFFICIENCY; PREECLAMPSIA; PREGNANCY; UMBILICAL ARTERY; VASCULAR RESISTANCE;

BLOOD FLOW VELOCITY; FEMALE; HUMANS; MIDDLE CEREBRAL ARTERY; NITROGLYCERIN; PLACENTAL INSUFFICIENCY; PRE-ECLAMPSIA; PREGNANCY; UMBILICAL ARTERIES; VASCULAR RESISTANCE;

EID: 80053214372     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.10067     Document Type: Note

References (44)

1. Page EW,. The relation between hydatid moles, relative ischemia of the gravid uterus, and the placental origin of eclampsia. Am J Obstet Gynecol 1939; 37: 291-293.
2. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, Sibai BM, Epstein FH, Romero R, Thadhani R, Karumanchi SA,; CPEP Study Group. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006; 355: 992-1005. (Pubitemid 44343543)
3. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA,. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111: 649-658. (Pubitemid 36278583)
4. Espinoza J, Uckele JE, Starr RA, Seubert DE, Espinoza AF, Berry SM,. Angiogenic imbalances: the obstetric perspective. Am J Obstet Gynecol 2010; 203: 17.e1-8.
5. Tjoa ML, van Vugt JM, Mulders MA, Schutgens RB, Oudejans CB, van Wijk IJ,. Plasma placenta growth factor levels in midtrimester pregnancies. Obstet Gynecol 2001; 98: 600-607. (Pubitemid 32907454)
6. Tidwell SC, Ho HN, Chiu WH, Torry RJ, Torry DS,. Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia. Am J Obstet Gynecol 2001; 184: 1267-1272. (Pubitemid 32434285)
7. Chappell LC, Seed PT, Briley A, Kelly FJ, Hunt BJ, Charnock-Jones DS, Mallet AI, Poston,. A longitudinal study of biochemical variables in women at risk of preeclampsia. Am J Obstet Gynecol 2002; 187: 127-136. (Pubitemid 34800311)
8. Taylor RN, Grimwood J, Taylor RS, McMaster MT, Fisher SJ, North RA,. Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies. Am J Obstet Gynecol 2003; 188: 177-182. (Pubitemid 36135616)
9. Polliotti BM, Fry AG, Saller DN, Mooney RA, Cox C, Miller RK,. Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset preeclampsia. Obstet Gynecol 2003; 101: 1266-1274. (Pubitemid 36694354)
10. Krauss T, Pauer HU, Augustin HG,. Prospective analysis of placenta growth factor (PlGF) concentrations in the plasma of women with normal pregnancy and pregnancies complicated by preeclampsia. Hypertens Pregnancy 2004; 23: 101-111. (Pubitemid 38445556)
11. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA,. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350: 672-683. (Pubitemid 38364626)
12. Parra M, Rodrigo R, Barja P, Bosco C, Fernandez V, Munoz H, Soto-Chacón E,. Screening test for preeclampsia through assessment of uteroplacental blood flow and biochemical markers of oxidative stress and endothelial dysfunction. Am J Obstet Gynecol 2005; 193: 1486-1491. (Pubitemid 41395121)
13. Chaiworapongsa T, Romero R, Kim YM, Kim GJ, Kim MR, Espinoza J, Bujold E, Gonçalves L, Gomez R, Edwin S, Mazor M,. Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia. J Matern Fetal Neonatal Med 2005; 17: 3-18. (Pubitemid 40515938)
14. Moore Simas TA, Crawford SL, Solitro MJ, Frost SC, Meyer BA, Maynard SE,. Angiogenic factors for the prediction of preeclampsia in high-risk women. Am J Obstet Gynecol 2007; 197: 244.e1-8.
15. Ohkuchi A, Hirashima C, Matsubara S, Suzuki H, Takahashi K, Arai F, Watanabe T, Kario K, Suzuki M,. Alterations in placental growth factor levels before and after the onset of preeclampsia are more pronounced in women with early onset severe preeclampsia. Hypertens Res 2007; 30: 151-159. (Pubitemid 46541789)
16. Poon LC, Zaragoza E, Akolekar R, Anagnostopoulos E, Nicolaides KH,. Maternal serum placental growth factor (PlGF) in small for gestational age pregnancy at 11(+0) to 13(+6) weeks of gestation. Prenat Diagn 2008; 28: 1110-1115.
17. Erez O, Romero R, Espinoza J, Fu W, Todem D, Kusanovic JP, Gotsch F, Edwin S, Nien JK, Chaiworapongsa T, Mittal P, Mazaki-Tovi S, Than NG, Gomez R, Hassan SS,. The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age. J Matern Fetal Neonatal Med 2008; 21: 279-287. (Pubitemid 351652513)
18. Poon LC, Kametas NA, Maiz N, Akolekar R, Nicolaides KH,. First-trimester prediction of hypertensive disorders in pregnancy. Hypertension 2009; 53: 812-818.
19. Thadhani R, Mutter WP, Wolf M, Levine RJ, Taylor RN, Sukhatme VP, Ecker J, Karumanchi SA,. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J Clin Endocrinol Metab 2004; 89: 770-775. (Pubitemid 38269892)
20. Rana S, Karumanchi SA, Levine RJ, Venkatesha S, Rauh-Hain JA, Tamez H, Thadhani R,. Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia. Hypertension 2007; 50: 137-142. (Pubitemid 46986022)
21. Baumann MU, Bersinger NA, Mohaupt MG, Raio L, Gerber S, Surbek DV,. First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia. Am J Obstet Gynecol 2008; 199: 266.e1-6.
22. Romero R, Nien JK, Espinoza J, Todem D, Fu W, Chung H, Kusanovic JP, Gotsch F, Erez O, Mazaki-Tovi S, Gomez R, Edwin S, Chaiworapongsa T, Levine RJ, Karumanchi SA,. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med 2008; 21: 9-23.
23. Schmidt M, Dogan C, Birdir C, Kuhn U, Gellhaus A, Kimmig R, Kasimir-Bauer S,. Placental growth factor: a predictive marker for preeclampsia? Gynakol Geburtshilfliche Rundsch 2009; 49: 94-99.
24. Espinoza J, Romero R, Nien JK, Gomez R, Kusanovic JP, Goncalves LF, Medina L, Edwin S, Hassan S, Carstens M, Gonzalez R,. Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor. Am J Obstet Gynecol 2007; 196: 326.e1-13.
25. Stepan H, Geipel A, Schwarz F, Kramer T, Wessel N, Faber R,. Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion. Am J Obstet Gynecol 2008; 198: 175.e1-6.
26. Wortelboer EJ, Koster MPH, Kuc S, Eijkemans MJC, Bilardo CM, Schielen PCJI, Visser GHA,. Longitudinal trends in fetoplacental biochemical markers, uterine artery pulsatility index and maternal blood pressure during the first trimester of pregnancy. Ultrasound Obstet Gynecol 2011; 38: 383-388.
27. Lin S, Shimizu I, Suehara N, Nakayama M, Aono T,. Uterine artery Doppler velocimetry in relation to trophoblast migration into the myometrium of the placental bed. Obstet Gynecol 1995; 85: 760-765.
28. Olofsson P, Laurini RN, Marsal K,. A high uterine artery pulsatility index reflects a defective development of placental bed spiral arteries in pregnancies complicated by hypertension and fetal growth retardation. Eur J Obstet Gynecol Reprod Biol 1993; 49: 161-168. (Pubitemid 23220935)
29. Aardema MW, Oosterhof H, Timmer A, van Rooy I, Aarnoudse JG,. Uterine artery Doppler flow and uteroplacental vascular pathology in normal pregnancies and pregnancies complicated by pre-eclampsia and small for gestational age fetuses. Placenta 2001; 22: 405-411. (Pubitemid 32519790)
30. Madazli R, Somunkiran A, Calay Z, Ilvan S, Aksu MF,. Histomorphology of the placenta and the placental bed of growth restricted foetuses and correlation with the Doppler velocimetries of the uterine and umbilical arteries. Placenta 2003; 24: 510-516. (Pubitemid 37184772)
31. Voigt HJ, Becker V,. Doppler flow measurements and histomorphology of the placental bed in uteroplacental insufficiency. J Perinat Med 1992; 20: 139-147.
32. Espinoza J, Romero R, Mee KY, Kusanovic JP, Hassan S, Erez O, Gotsch F, Than NG, Papp Z, Jai Kim C,. Normal and abnormal transformation of the spiral arteries during pregnancy. J Perinat Med 2006; 34: 447-458. (Pubitemid 44877386)
33. Pijnenborg R, Vercruysse L, Hanssens M,. The uterine spiral arteries in human pregnancy: facts and controversies. Placenta 2006; 27: 939-958. (Pubitemid 44204033)
34. Sandrim VC, Palei AC, Cavalli RC, Araujo FM, Ramos ES, Duarte G, Tanus-Santos JE,. Vascular endothelial growth factor genotypes and haplotypes are associated with pre-eclampsia but not with gestational hypertension. Mol Hum Reprod 2009; 15: 115-120.
35. Audibert F, Salomon LJ, Castaigne-Meary V, Alves K, Frydman R,. Selective termination of a twin pregnancy as a treatment of severe pre-eclampsia. BJOG 2003; 110: 68-69. (Pubitemid 36034297)
36. Hagay ZJ, Levy R, Zalel Y, Weissman A,. Single fetal demise in twin gestation resulting in the resolution of severe pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 1994; 56: 137-138. (Pubitemid 24281332)
37. Sarhanis P, Pugh DH,. Resolution of pre-eclampsia following intrauterine death of one twin. Br J Obstet Gynaecol 1992; 99: 159-160.
38. Duthie SJ, Walkinshaw SA,. Parvovirus associated fetal hydrops: reversal of pregnancy induced proteinuric hypertension by in utero fetal transfusion. Br J Obstet Gynaecol 1995; 102: 1011-1013. (Pubitemid 26015000)
39. Chaiworapongsa T, Espinoza J, Gotsch F, Kim YM, Kim GJ, Goncalves LF, Edwin S, Kusanovic JP, Erez O, Than NG, Hassan SS, Romero R,. The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation. J Matern Fetal Neonatal Med 2008; 21: 25-40.
40. Schlembach D, Wallner W, Sengenberger R, Stiegler E, Mortl M, Beckmann MW, Lang U,. Angiogenic growth factor levels in maternal and fetal blood: correlation with Doppler ultrasound parameters in pregnancies complicated by pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol 2007; 29: 407-413. (Pubitemid 46632236)
41. Slegel P, Kitagawa H, Maguire MH,. Determination of adenosine in fetal perfusates of human placental cotyledons using fluorescence derivatization and reversed-phase high-performance liquid chromatography. Anal Biochem 1988; 171: 124-134.
42. George EM, Cockrell K, Adair TH, Granger JP,. Regulation of sFlt-1 and VEGF secretion by adenosine under hypoxic conditions in rat placental villous explants. Am J Physiol Regul Integr Comp Physiol 2010; 299: R1629-R1633.
43. Espinoza J, Espinoza AF, Power GG,. High fetal plasma adenosine: A role for the fetus in preeclampsia? Am J Obstet Gynecol 2011; DOI: 10.1016/j.ajog.2011.06.034.
44. Trapani Jr A, Gonçalves LF, Pires MM,. Transdermal nitroglycerin in patients with severe pre-eclampsia with placental insufficiency: effect on uterine, umbilical and fetal middle cerebral artery resistance indices. Ultrasound Obstet Gynecol 2011; 38: 389-394.